Aljoharah M. Algabbani

Saudi Food and Drug Authority (Saudi FDA), Saudi Arabia

Poster(s):

• (202) Pediatric Drug Safety Surveillance in Saudi Arabia: A Description of Adverse Drug Reactions from The Saudi Vigilance Database
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (9) Readability of Information Imprinted in Patient Information Leaflets (PILs) in Saudi Arabia: The Case of Antihypertensive Medications
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST